Research Vendor
NextGen Peptides
- 23 compounds tested
- Registered Mar 2025
- COAs on file
- 53
- Independently confirmed
- 0
- Median purity
- 99.79%
- At or above market
- 17/23
- Most recent
- 8 Jul
across 2 labs
none on record
▲ 0.11 vs corpus
compounds comparable
2 months ago
ngpeptide.com · registered 2025 · 1y 5m old · transfer-locked · registry checked 29 Jul 2026Registry detail
- Registered
- 19 Mar 2025
- Registry expiry
- 19 Mar 2028
- Record last changed
- 8 Apr 2026
- EPP status
- client transfer prohibited
- Source
- RDAP registry
- First indexed by us
- 3 Jul 2026
Research use only. This vendor supplies peptides for laboratory and research purposes — not for human consumption or therapeutic use. PeptideBase does not endorse or guarantee product quality. Verify third-party lab testing before any research use.
Vendor's own wordPublishes 2 of 6 disclosure signals — 1 document-backed, 1 vendor-stated · checked 17 Aug 2026
Vendor-supplied · Not verified by PeptideBase
What this vendor publishes about itself, repeated here. Disclosure is not verification; only independent lab results change that.
53 certificates on file, all self-published by the vendor. Median purity 99.79%, against 99.68% across all 928 certificates we score. Seventeen of 23 compounds test at or above their market median. The exception is a Kisspeptin-10 lot at 99.01% — 0.62 points below the 99.63% median for that compound, and the only result here outside the corpus's middle 80%.
Where this evidence comes from
Evidence provenance
- 53 self-published
- COAs the vendor posted on their own site.
Recorded for completeness. A self-published document doesn't count as confirmed on its own — the document is real, the chain of custody isn't independent.
Purity vs market
Every certificate, placed against the median for its own compound across all 928 results we score.
40 of 48 results sit within ±0.4 points of their market median.
Lab-sourcedSelf-published
5 further results are not plotted — no purity figure, or too few market results for that compound to compare against. They appear in the table below.
Lab testing record
Every COA we hold for NextGen Peptides.
How these certificates can be checked
Of the 53 certificates we hold for NextGen Peptides:
- 18Carries a lookup reference
- 33No lookup reference on the report
- 2Lab lookup not established
These do not all sit in the same state, so no single statement covers them. Each certificate below says which applies to it.
| Panel | Source | Reference | |||||
|---|---|---|---|---|---|---|---|
| Sermorelin | ILS Laboratories | 8 Jul 26 | 99.57% | +0.26 | — | Self-published | — |
| ILS Laboratories publishes a report lookup and this certificate carries the reference it needs. No lookup result is recorded. | |||||||
| Selank | ILS Laboratories | 8 Jul 26 | 99.56% | −0.18 | — | Self-published | — |
| ILS Laboratories publishes a report lookup and this certificate carries the reference it needs. No lookup result is recorded. | |||||||
| Tesamorelin | ILS Laboratories | 8 Jul 26 | 99.60% | +0.16 | — | Self-published | — |
| ILS Laboratories publishes a report lookup and this certificate carries the reference it needs. No lookup result is recorded. | |||||||
| DSIP | ILS Laboratories | 8 Jul 26 | 99.87% | +0.56 | — | Self-published | — |
| ILS Laboratories publishes a report lookup and this certificate carries the reference it needs. No lookup result is recorded. | |||||||
| Thymosin Alpha-1 | ILS Laboratories | 8 Jul 26 | 99.47% | −0.22 | — | Self-published | — |
| ILS Laboratories publishes a report lookup and this certificate carries the reference it needs. No lookup result is recorded. | |||||||
| BPC-157 | ILS Laboratories | 8 Jul 26 | 99.90% | +0.18 | — | Self-published | — |
| ILS Laboratories publishes a report lookup and this certificate carries the reference it needs. No lookup result is recorded. | |||||||
| TB-500 | ILS Laboratories | 8 Jul 26 | 99.58% | +0.13 | — | Self-published | — |
| ILS Laboratories publishes a report lookup and this certificate carries the reference it needs. No lookup result is recorded. | |||||||
| Tirzepatide | ILS Laboratories | 8 Jul 26 | 99.91% | +0.11 | — | Self-published | — |
| ILS Laboratories publishes a report lookup and this certificate carries the reference it needs. No lookup result is recorded. | |||||||
| Kisspeptin-10 | ILS Laboratories | 8 Jul 26 | 99.01% | −0.62 | — | Self-published | — |
| ILS Laboratories publishes a report lookup and this certificate carries the reference it needs. No lookup result is recorded. | |||||||
| AOD-9604 | ILS Laboratories | 8 Jul 26 | 99.68% | +0.01 | — | Self-published | View COA ↗ |
| ILS Laboratories publishes a report lookup and this certificate carries the reference it needs. No lookup result is recorded. | |||||||
| Glutathione | ILS Laboratories | 4 Jul 26 | 99.17% | −0.27 | — | Self-published | — |
| ILS Laboratories publishes a report lookup and this certificate carries the reference it needs. No lookup result is recorded. | |||||||
| MOTS-c | ILS Laboratories | 28 Jun 26 | 99.86% | +0.45 | — | Self-published | — |
| ILS Laboratories publishes a report lookup and this certificate carries the reference it needs. No lookup result is recorded. | |||||||
| Retatrutide | ILS Laboratories | 25 Jun 26 | 99.94% | +0.21 | — | Self-published | — |
| ILS Laboratories publishes a report lookup and this certificate carries the reference it needs. No lookup result is recorded. | |||||||
| PT-141 | ILS Laboratories | 25 Jun 26 | 99.97% | +0.08 | — | Self-published | — |
| ILS Laboratories publishes a report lookup and this certificate carries the reference it needs. No lookup result is recorded. | |||||||
| MOTS-c | ILS Laboratories | 12 Jun 26 | — | no purity figure | Yes | Self-published | — |
| ILS Laboratories publishes a report lookup. This certificate does not carry a reference we can use with it. | |||||||
| Retatrutide | ILS Laboratories | 9 Jun 26 | 99.14% | −0.59 | — | Self-published | — |
| ILS Laboratories publishes a report lookup and this certificate carries the reference it needs. No lookup result is recorded. | |||||||
| Selank | ILS Laboratories | 5 Jun 26 | — | no purity figure | Yes | Self-published | — |
| ILS Laboratories publishes a report lookup. This certificate does not carry a reference we can use with it. | |||||||
| Tirzepatide | ILS Laboratories | 5 Jun 26 | 99.90% | +0.10 | — | Self-published | — |
| ILS Laboratories publishes a report lookup and this certificate carries the reference it needs. No lookup result is recorded. | |||||||
| Semax | ILS Laboratories | 5 Jun 26 | — | no purity figure | Yes | Self-published | — |
| ILS Laboratories publishes a report lookup. This certificate does not carry a reference we can use with it. | |||||||
| Retatrutide | ILS Laboratories | 1 Jun 26 | 99.89% | +0.16 | — | Self-published | — |
| ILS Laboratories publishes a report lookup and this certificate carries the reference it needs. No lookup result is recorded. | |||||||
| BPC-157 | ILS Laboratories | 25 May 26 | — | no purity figure | Yes | Self-published | — |
| ILS Laboratories publishes a report lookup. This certificate does not carry a reference we can use with it. | |||||||
| AOD-9604 | ILS Laboratories | 25 May 26 | — | no purity figure | Yes | Self-published | — |
| ILS Laboratories publishes a report lookup. This certificate does not carry a reference we can use with it. | |||||||
| 5-Amino-1MQ | ILS Laboratories | 24 May 26 | 99.98% | +0.23 | — | Self-published | View COA ↗ |
| ILS Laboratories publishes a report lookup and this certificate carries the reference it needs. No lookup result is recorded. | |||||||
| 5-Amino-1MQ | ILS Laboratories | 24 May 26 | 99.98% | +0.23 | Yes | Self-published | View COA ↗ |
| ILS Laboratories publishes a report lookup. This certificate does not carry a reference we can use with it. | |||||||
| MOTS-c | ILS Laboratories | 23 May 26 | 99.04% | −0.37 | — | Self-published | — |
| ILS Laboratories publishes a report lookup. This certificate does not carry a reference we can use with it. | |||||||
| KPV | ILS Laboratories | 22 May 26 | 99.72% | +0.24 | — | Self-published | — |
| ILS Laboratories publishes a report lookup. This certificate does not carry a reference we can use with it. | |||||||
| NAD+ | ILS Laboratories | 10 May 26 | 99.83% | +0.28 | — | Self-published | — |
| ILS Laboratories publishes a report lookup. This certificate does not carry a reference we can use with it. | |||||||
| TB-500 | ILS Laboratories | 10 May 26 | 99.87% | +0.42 | — | Self-published | — |
| ILS Laboratories publishes a report lookup. This certificate does not carry a reference we can use with it. | |||||||
| Ipamorelin | ILS Laboratories | 7 May 26 | 99.64% | −0.15 | — | Self-published | — |
| ILS Laboratories publishes a report lookup. This certificate does not carry a reference we can use with it. | |||||||
| Epithalon | ILS Laboratories | 7 May 26 | 99.01% | −0.32 | — | Self-published | — |
| ILS Laboratories publishes a report lookup. This certificate does not carry a reference we can use with it. | |||||||
| BPC-157 | ILS Laboratories | 7 May 26 | 99.28% | −0.44 | — | Self-published | — |
| ILS Laboratories publishes a report lookup. This certificate does not carry a reference we can use with it. | |||||||
| Thymosin Alpha-1 | ILS Laboratories | 6 May 26 | 99.68% | −0.01 | — | Self-published | — |
| ILS Laboratories publishes a report lookup. This certificate does not carry a reference we can use with it. | |||||||
| Cagrilintide | ILS Laboratories | 6 May 26 | 99.35% | −0.31 | — | Self-published | — |
| ILS Laboratories publishes a report lookup. This certificate does not carry a reference we can use with it. | |||||||
| Tirzepatide | ILS Laboratories | 6 May 26 | 99.93% | +0.13 | — | Self-published | — |
| ILS Laboratories publishes a report lookup. This certificate does not carry a reference we can use with it. | |||||||
| Tirzepatide | ILS Laboratories | 6 May 26 | 99.92% | +0.12 | — | Self-published | — |
| ILS Laboratories publishes a report lookup. This certificate does not carry a reference we can use with it. | |||||||
| Cagrilintide | ILS Laboratories | 6 May 26 | 99.85% | +0.19 | — | Self-published | — |
| ILS Laboratories publishes a report lookup. This certificate does not carry a reference we can use with it. | |||||||
| Semax | ILS Laboratories | 6 May 26 | 99.77% | +0.40 | — | Self-published | — |
| ILS Laboratories publishes a report lookup. This certificate does not carry a reference we can use with it. | |||||||
| TB-500 | ILS Laboratories | 6 May 26 | 99.85% | +0.40 | — | Self-published | — |
| ILS Laboratories publishes a report lookup. This certificate does not carry a reference we can use with it. | |||||||
| Tirzepatide | ILS Laboratories | 6 May 26 | 99.89% | +0.09 | — | Self-published | — |
| ILS Laboratories publishes a report lookup. This certificate does not carry a reference we can use with it. | |||||||
| VIP | ILS Laboratories | 21 Apr 26 | 99.95% | +0.26(n=8) | — | Self-published | — |
| ILS Laboratories publishes a report lookup. This certificate does not carry a reference we can use with it. | |||||||
| NAD+ | ILS Laboratories | 21 Apr 26 | 99.55% | ±0.00 | — | Self-published | — |
| ILS Laboratories publishes a report lookup. This certificate does not carry a reference we can use with it. | |||||||
| GHK-Cu | ILS Laboratories | 21 Apr 26 | 99.89% | +0.10 | — | Self-published | — |
| ILS Laboratories publishes a report lookup. This certificate does not carry a reference we can use with it. | |||||||
| Sermorelin | ILS Laboratories | 21 Apr 26 | 99.91% | +0.60 | — | Self-published | — |
| ILS Laboratories publishes a report lookup. This certificate does not carry a reference we can use with it. | |||||||
| Retatrutide | ILS Laboratories | 16 Apr 26 | 99.30% | −0.43 | — | Self-published | — |
| ILS Laboratories publishes a report lookup. This certificate does not carry a reference we can use with it. | |||||||
| Retatrutide | ILS Laboratories | 16 Apr 26 | 99.80% | +0.07 | — | Self-published | — |
| ILS Laboratories publishes a report lookup. This certificate does not carry a reference we can use with it. | |||||||
| PT-141 | ILS Laboratories | 16 Apr 26 | 99.95% | +0.06 | — | Self-published | — |
| ILS Laboratories publishes a report lookup. This certificate does not carry a reference we can use with it. | |||||||
| Selank | ILS Laboratories | 16 Apr 26 | 99.68% | −0.06 | — | Self-published | — |
| ILS Laboratories publishes a report lookup. This certificate does not carry a reference we can use with it. | |||||||
| Retatrutide | ILS Laboratories | 16 Apr 26 | 99.96% | +0.23 | — | Self-published | — |
| ILS Laboratories publishes a report lookup. This certificate does not carry a reference we can use with it. | |||||||
| Tesamorelin | ILS Laboratories | 16 Apr 26 | 99.40% | −0.04 | — | Self-published | — |
| ILS Laboratories publishes a report lookup. This certificate does not carry a reference we can use with it. | |||||||
| Kisspeptin-10 | ILS Laboratories | 31 Mar 26 | 99.30% | −0.33 | — | Self-published | — |
| ILS Laboratories publishes a report lookup. This certificate does not carry a reference we can use with it. | |||||||
| DSIP | ILS Laboratories | 31 Mar 26 | 99.55% | +0.24 | — | Self-published | — |
| ILS Laboratories publishes a report lookup. This certificate does not carry a reference we can use with it. | |||||||
| 5-Amino-1MQ | BioRegen | 3 Oct 25 | 99.90% | +0.15 | — | Self-published | View COA ↗ |
| We have not established whether BioRegen publishes a report lookup. | |||||||
| AOD-9604 | BioRegen | 10 Sept 25 | 99.63% | −0.04 | — | Self-published | View COA ↗ |
| We have not established whether BioRegen publishes a report lookup. | |||||||
53 certificates
The labs behind these results
In the vendor's own words
Written by the vendor · Not verified by PeptideBase
NextGen Peptides specializes in providing precision-synthesized peptides for research purposes. They focus on quality assurance through third-party testing and batch-level traceability, ensuring transparency and documented purity.
#Testing disclosure
- Publishes COAsVendor-stated
- Yes
- COA accessVendor-stated
- Published on the vendor’s website
- Last observedOur record
- 6 Jul 2026
- Batch numbers shownOur record
- Yes
Research pricing
Lowest tracked SKU per compound. $/mg is the comparable figure; the range spans the middle 50% of vendors.
Tracked prices9 of 17 compounds
| Compound | Price | Size | $/mg | vs tracked range | SKUs |
|---|---|---|---|---|---|
| Glutathione | $45.00 | 1500 mg | $0.03 | $0.03$0.09 | 1 |
| Ipamorelin | $28.00 | 1 vial | $5.60 | $4.88$8.05 | 1 |
| Kisspeptin-10 | $35.00 | 10 mg | $3.50 | $4.50$8.00 | 1 |
| MOTS-c | $80.00 | 40 mg | $2.00 | $3.03$6.96 | 2 |
| NAD+ | $50.00 | 500 mg | $0.10 | $0.10$0.18 | 1 |
| PT-141 | $24.99 | 10 mg | $2.50 | $3.22$4.50 | 1 |
| Retatrutide | $165.00 | 50 mg | $3.30 | $8.50$11.45 | 1 |
| Selank | $30.00 | 10 mg | $3.00 | $4.02$5.49 | 2 |
| Semax | $35.00 | 1 kit | $3.50 | $3.52$5.50 | 1 |
Prices may vary by quantity — verify directly with the vendor.Report a pricing error
Research catalog
17 compounds listed. Linked entries have a research summary in the library.
Cartalax
DSIP
Epithalon
GHK-Cu
Glutathione$0.03/mg
Ipamorelin$5.60/mg
Kisspeptin-10$3.50/mg
KPV
MOTS-c$2.00/mg
NAD+$0.10/mg
PT-141$2.50/mg
Retatrutide$3.30/mg
9 priced · 8 listed without a tracked priceCompare all 17 across vendors →
Add this badge to your website
Profile last updated
Cite this page
Free to reference and republish with attribution to PeptideBase. Choose a format:
PeptideBase. (2026). NextGen Peptides — Research Vendor Profile. Retrieved September 11, 2026, from https://peptidebase.io/research-vendors/nextgen-peptides